Specialty Pharmacy

This video summarizes the research findings from ECTRIMS 2012.

EMD Serono, Inc, a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc announced today that the FDA approved Rebif Rebidose (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS).

Managed Health Care Associates, Inc (MHA), a leading health care service company focused on alternate site providers, is pleased to announce the acquisition of FMS Purchasing & Services, Inc and the Rebate Tracking Group (RTG) through its Navigator Group Purchasing subsidiary.

Looking for mobile apps relevant to your specialty business? Here are 7 recommendations from the editors of Specialty Pharmacy Times.

Clinical pathway programs in oncology will be utilized with more frequency in the coming years and may be instrumental in changing prescribing behavior, according to researchers from Decision Resources.

2 major HIV provider groups recently sent pharmaceutical companies and manufacturers a statement urging them to make their antiretrovirals more accessible to patients.

Adam J. Fein, PhD, discussed how wholesaler strategies must change in order to navigate an evolving drug channel infrastructure at the recent 8th Annual Trade and Channel Strategies Conference.

FDA granted accelerated approval to Iclusig (ponatinib) for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.

Eight-year follow-up data from the phase III HERA trial has confirmed that 1-year of adjuvant trastuzumab should remain the treatment standard in women with HER2-positive early-stage breast cancer.

Aetna and Cardinal Health Specialty Solutions announced today an evidence-based program designed to improve cancer care in Michigan.

Commercial health plans have recently started limiting the use of manufacturer copay cards to encourage formulary compliance. The question remains-how will Medicare handle these coupons?

The FDA today expanded the approved use of Zytiga (abiraterone acetate) to treat men with late-stage (metastatic) castration-resistant prostate cancer prior to receiving chemotherapy.

The deal with GlaxoSmithKline to develop an MD Anderson discovery draws on the expertise of the Institute for Applied Cancer Science.

There have been significant increases in the cost of antiretroviral therapies (ART) for individual therapies and in the cost of therapy initiation over the past several years.

The adoption of clinical pathways helps to standardize the cancer care process, and this practice is becoming increasingly popular.

Rapid growth, expanding specialty drug market propel hiring at nation's largest privately held specialty pharmacy.

The new Indianapolis facility will support Catamaran's win of the $60 million, 6-year State of Indiana Medicaid contract.

Diplomat Specialty Pharmacy and Exelixis, Inc announced today that Diplomat Specialty Pharmacy has been selected as the exclusive specialty pharmacy for Cometriq (cabozantinib).

Connexus Technology recently announced it has been recognized as the 2012 Health Care Innovation Consultant of the Year by the Philadelphia Business Journal and presenting sponsor United Healthcare.

Novo Nordisk announced the introduction of HemaGo, a mobile application (app) to help individuals with hemophilia and their caregivers monitor the details of treatment, including medications, dosing, bleed information and the impact of hemophilia on life events.

By prescribing clinically similar luteinizing hormone–releasing hormone agonists for the treatment of prostate cancer, Medicare could have saved 13% of its total budget for monthly injections, according to a study from the Office of the Inspector General.

In a retrospective analysis, researchers concluded that rheumatoid arthritis patients had better outcomes when they filled their prescriptions through a mail-order specialty pharmacy rather than a retail pharmacy.

New recommendations from the task force say that all Americans aged 15 to 64 years should get an HIV test regardless of their risk for contracting the virus.

In an exclusive interview with Specialty Pharmacy Times, Albert Thigpen, Senior Vice President of Pharmacy Operations & Industry Relations at Catamaran Corporation, spoke about his distinct responsibilities surrounding the management of pharmaceutical manufacturers, Catamaran's 3 mail order pharmacies, and BriovaRx's 11 specialty pharmacies.

A recent study featured in the American Journal of Pharmacy Benefits examines the role of patient out-of-pocket cost on adherence to disease-modifying therapies for multiple sclerosis.

At a meeting hosted by the American Journal of Managed Care, key figures in the managed care industry discussed innovative payment models being utilized by payers and providers.

Pfizer's Xeljanz (tofacitinib) is the first Janus kinase inhibitor approved for rheumatoid arthritis and the first oral biologic within the RA class. Dina Rufo of GlobalData discusses the factors that will affect uptake of the drug.

Community Specialty Pharmacy Network, Inc (CSPN), recently announced a distribution agreement with Dara BioSciences for Soltamox (tamoxifen citrate), a nonsteroidal antiestrogen for the treatment of patients with breast cancer.